Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-28

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for methylphenidate hydrochloride from XLCare Pharmaceuticals, Inc., establishing a generic version of the ADHD medicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)